Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorCombined Modality TherapyLeukapheresisHematologic NeoplasmsAntigens, CD34Blood Component RemovalHodgkin DiseaseStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsBusulfanGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinDuodenoscopyGraft SurvivalBone Marrow TransplantationEtoposideHematopoietic Stem CellsThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisCrohn DiseaseStem CellsCytarabineHematopoiesisDisease-Free SurvivalCord Blood Stem Cell TransplantationTransplantation ChimeraRetrospective StudiesNeoplasmsSurvival RateTissue DonorsWhole-Body IrradiationSurvival AnalysisLymphoma, T-CellDoxorubicinTime FactorsInfectionHistocompatibilityPOEMS SyndromePlatelet CountPrednisoneCarboplatinHistocompatibility TestingImmunosuppressive AgentsLeukemia, Myeloid, AcuteTransplantation, IsogeneicDexamethasoneVidarabineFollow-Up StudiesBlood Cell CountRecombinant ProteinsLeukemiaAntineoplastic AgentsLymphomaBone Marrow PurgingProspective StudiesCytomegalovirus InfectionsBlood CellsFatal OutcomeGraft vs Leukemia EffectFeasibility StudiesImmunophenotypingMyelodysplastic SyndromesAnemia, AplasticBlood Transfusion, AutologousLiver TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionT-LymphocytesLeukocytes, MononuclearPrognosisHistiocytosis, Non-Langerhans-CellLivedo ReticularisHematologic DiseasesOpportunistic InfectionsBone MarrowPrecursor Cell Lymphoblastic Leukemia-LymphomaHLA AntigensBreast NeoplasmsCyclosporineBlood DonorsImmunosuppression